# EDGAR Filing Document

**Accession Number:** 0001316774
**File Stem:** 0001437749-25-025153
**Filing Date:** 2025-8
**Character Count:** 7701
**Document Hash:** 7d9133b5d9a2ff94e9d6ee36512fccfc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-025153.hdr.sgml**: 20250806

**ACCESSION NUMBER**: 0001437749-25-025153

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250804

**FILED AS OF DATE**: 20250806

**DATE AS OF CHANGE**: 20250806

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Pruitt William D
- **CENTRAL INDEX KEY:** 0001316774

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35849
- **FILM NUMBER:** 251190962

**MAIL ADDRESS:**
- **STREET 1:** C/O KOS PHARMACEUTICALS, INC.
- **STREET 2:** 2200 N. COMMERCE PKWY., SUITE 300
- **CITY:** WESTON
- **STATE:** FL
- **ZIP:** 33326-3258
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NV5 Global, Inc.
- **CENTRAL INDEX KEY:** 0001532961
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 453458017
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0103

**BUSINESS ADDRESS:**
- **STREET 1:** 200 SOUTH PARK ROAD
- **STREET 2:** SUITE 350
- **CITY:** HOLLYWOOD
- **STATE:** FL
- **ZIP:** 33021
- **BUSINESS PHONE:** (954) 495-2112

**MAIL ADDRESS:**
- **STREET 1:** 200 SOUTH PARK ROAD
- **STREET 2:** SUITE 350
- **CITY:** HOLLYWOOD
- **STATE:** FL
- **ZIP:** 33021

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NV5 Holdings, Inc.
- **DATE OF NAME CHANGE:** 20111018

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[x] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Pruitt William D<br><sub>(Last) (First) (Middle)</sub><br>200 SOUTH PARK RD.<br>SUITE 350<br><sub>(Street)</sub><br>HOLLYWOOD, FL 33021<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-08-04 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>NV5 Global, Inc. [ NVEE ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-08-04 |  | D |  | 2000<sup>(4)</sup> | D | <sup>(3)</sup> | 0 | I | Ileana O Pruitt Living Trust<sup>(1)</sup> |
| Common Stock | 2025-08-04 |  | D |  | 32000<sup>(4)</sup> | D | <sup>(3)</sup> | 0 | D |  |
| Common Stock | 2025-08-04 |  | D |  | 564<sup>(4)</sup> | D | <sup>(3)</sup> | 0 | I | The William D. Pruitt Jr. Living Trust |
| Common Stock | 2025-08-04 |  | D |  | 50000<sup>(4)</sup> | D | <sup>(3)</sup> | 0 | I | Pruitt Enterprises LP<sup>(2)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Mr. Pruitt disclaims beneficial ownership of the securities indicated, and the reporting herein of such securities, shall not be construed as an admission that the undersigned is the beneficial owner thereof forpurposes of Section 16 or for any other purpose.

(2) Mr. Pruitt is the President of Pruitt Ventures, Inc. which is the general partner of Pruitt Enterprises, LP and has voting and dispositive power with respect to these shares. Mr. Pruitt disclaims beneficial ownership except to the extent of any indirect pecuniary interest therein.

(3) Pursuant to the Agreement and Plan of Merger, dated as of May 14, 2025 (the "Merger Agreement"), by and among NV5 Global, Inc. (the "Company"), Acuren Corporation ("Acuren"), Ryder Merger Sub I, Inc. and Ryder Merger Sub II, Inc., each outstanding share of common stock of the Issuer was converted into the right to receive 1.1523 shares of Acuren common stock per share and $10.00 in cash per share (together, the "Merger Consideration"). In addition, pursuant to the Merger Agreement, any outstanding restricted stock units of NV5 held by the Reporting Person automatically vested in full in accordance with its terms immediately prior to the effective time of the mergers and converted into the right to receive the Merger Consideration, less applicable tax withholdings.

(4) NV5 Global, Inc.'s, Board of Directors authorized a 4-for-1 stock split of its common stock, effective on a split-adjusted basis on October 11, 2024. The securities beneficially owned following this reported transaction accounts for this 4-for-1 stock split.

**Signature:** /s/ MaryJo OBrien, as attorney in fact  
**Date:** 2025-08-06

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**